{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T16:59:40Z","timestamp":1757609980726,"version":"3.44.0"},"reference-count":97,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T00:00:00Z","timestamp":1756080000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007195","name":"University of Naples Federico II","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007195","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pulmonary Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.pupt.2025.102385","type":"journal-article","created":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T21:55:25Z","timestamp":1755554125000},"page":"102385","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Exploring the role of \u03b22- and \u03b23-adrenergic receptors in cystic fibrosis"],"prefix":"10.1016","volume":"90","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8948-5961","authenticated-orcid":false,"given":"Alessandro","family":"Cannavo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marika","family":"Comegna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alice","family":"Castaldo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caterina","family":"Vinciguerra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Lauritano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulia Renata","family":"Franco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanna","family":"Casoria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Graziamaria","family":"Corbi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Rengo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Castaldo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.pupt.2025.102385_bib1","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/s41598-024-84191-9","article-title":"Metabolomic profiling of saliva from cystic fibrosis patients","volume":"15","author":"Caterino","year":"2025","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.pupt.2025.102385_bib2","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.gene.2014.02.040","article-title":"CFTR genotype and clinical outcomes of adult patients carried as cystic fibrosis disease","volume":"540","author":"Bonadia","year":"2014","journal-title":"Gene"},{"key":"10.1016\/j.pupt.2025.102385_bib3","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2147\/TACG.S18675","article-title":"Disease-modifying genes and monogenic disorders: Experience in cystic fibrosis","volume":"7","author":"Gallati","year":"2014","journal-title":"Appl. Clin. Genet."},{"issue":"19","key":"10.1016\/j.pupt.2025.102385_bib4","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1056\/NEJMra043184","article-title":"Cystic fibrosis","volume":"352","author":"Rowe","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.pupt.2025.102385_bib5","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1186\/s12890-018-0766-6","article-title":"Clinical expression of cystic fibrosis in a large cohort of Italian siblings","volume":"18","author":"Terlizzi","year":"2018","journal-title":"BMC Pulm. Med."},{"key":"10.1016\/j.pupt.2025.102385_bib6","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1136\/thx.53.12.1018","article-title":"Contribution of genetic factors other than CFTR to disease severity in cystic fibrosis","volume":"53","author":"Hull","year":"1998","journal-title":"Thorax"},{"issue":"4","key":"10.1016\/j.pupt.2025.102385_bib7","doi-asserted-by":"crossref","first-page":"562","DOI":"10.3390\/genes12040562","article-title":"Cystic fibrosis lung disease modifiers and their relevance in the new era of precision medicine","volume":"12","author":"Sepahzad","year":"2021","journal-title":"Genes (Basel)"},{"issue":"4","key":"10.1016\/j.pupt.2025.102385_bib8","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1375\/136905200320565256","article-title":"Categories of deltaF508 homozygous cystic fibrosis twin and sibling pairs with distinct phenotypic characteristics","volume":"3","author":"Mekus","year":"2000","journal-title":"Twin Res."},{"issue":"24","key":"10.1016\/j.pupt.2025.102385_bib9","doi-asserted-by":"crossref","first-page":"5821","DOI":"10.3390\/jcm10245821","article-title":"Genetic modifying factors of cystic fibrosis phenotype: a challenge for modern medicine","volume":"10","author":"Butnariu","year":"2021","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.pupt.2025.102385_bib10","doi-asserted-by":"crossref","first-page":"8382","DOI":"10.1038\/ncomms9382","article-title":"Genome-wide association meta-analysis identifies five modifier loci of lung disease severity in cystic fibrosis","volume":"6","author":"Corvol","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.pupt.2025.102385_bib11","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/ng.838","article-title":"Genome-wide association and linkage identify modifier loci of lung disease severity in cystic fibrosis at 11p13 and 20q13","volume":"43","author":"Wright","year":"2011","journal-title":"Nat. Genet."},{"key":"10.1016\/j.pupt.2025.102385_bib12","first-page":"1039","article-title":"Identification of IFRD1 as a modifier gene for cystic fibrosis lung disease","volume":"458","author":"Gu","year":"2009","journal-title":"Nat. Cell Biol."},{"issue":"1","key":"10.1016\/j.pupt.2025.102385_bib13","doi-asserted-by":"crossref","first-page":"5806","DOI":"10.1038\/s41598-020-62747-9","article-title":"TAS2R38 is a novel modifier gene in patients with cystic fibrosis","volume":"10","author":"Castaldo","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.pupt.2025.102385_bib14","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1471-2466-12-50","article-title":"Polymorphisms in ADRB2 gene can modulate the response to bronchodilators and the severity of cystic fibrosis","volume":"12","author":"Marson","year":"2012","journal-title":"BMC Pulm. Med."},{"issue":"6","key":"10.1016\/j.pupt.2025.102385_bib15","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1097\/FPC.0b013e3280119349","article-title":"Beta-2-adrenergic receptor polymorphisms in cystic fibrosis","volume":"17","author":"Steagall","year":"2007","journal-title":"Pharmacogenet. Genom."},{"key":"10.1016\/j.pupt.2025.102385_bib16","doi-asserted-by":"crossref","first-page":"264","DOI":"10.3389\/fphys.2013.00264","article-title":"Targeting cardiac beta-adrenergic signaling via GRK2 inhibition for heart failure therapy","volume":"4","author":"Cannavo","year":"2013","journal-title":"Front. Physiol."},{"issue":"2","key":"10.1016\/j.pupt.2025.102385_bib17","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/FJC.0000000000000444","article-title":"Targeting \u03b23-adrenergic receptors in the heart: selective agonism and \u03b2-blockade","volume":"69","author":"Cannavo","year":"2017","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"3","key":"10.1016\/j.pupt.2025.102385_bib18","first-page":"118","article-title":"G-protein-coupled receptors and their (bio)chemical significance win 2012 Nobel Prize in chemistry","volume":"36","author":"Lin","year":"2013","journal-title":"Biom. J."},{"issue":"6","key":"10.1016\/j.pupt.2025.102385_bib19","first-page":"733","article-title":"Tracheal mucociliary transport in patients with cystic fibrosis and its stimulation by terbutaline","volume":"111","author":"Wood","year":"1975","journal-title":"Am. Rev. Respir. Dis."},{"issue":"26","key":"10.1016\/j.pupt.2025.102385_bib20","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1056\/NEJM198006263022605","article-title":"Abnormal adrenergic and cholinergic sensitivity in cystic fibrosis","volume":"302","author":"Davis","year":"1980","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.pupt.2025.102385_bib21","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1172\/JCI110241","article-title":"Impaired beta adrenergic receptor binding and function in cystic fibrosis neutrophils","volume":"68","author":"Galant","year":"1981","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.pupt.2025.102385_bib22","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1126\/science.2425436","article-title":"Altered regulation of airway epithelial cell chloride channels in cystic fibrosis","volume":"233","author":"Frizzell","year":"1986","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.pupt.2025.102385_bib23","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1172\/JCI111385","article-title":"Defective beta adrenergic response of cystic fibrosis sweat glands in vivo and in vitro","volume":"73","author":"Sato","year":"1984","journal-title":"J. Clin. Investig."},{"issue":"8514","key":"10.1016\/j.pupt.2025.102385_bib24","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/S0140-6736(86)92616-4","article-title":"Defective beta-adrenergic secretory responses in submandibular acinar cells from cystic fibrosis patients","volume":"2","author":"McPherson","year":"1986","journal-title":"Lancet"},{"key":"10.1016\/j.pupt.2025.102385_bib25","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1073\/pnas.0135434100","article-title":"A macromolecular complex of \u03b22 adrenergic receptor, CFTR, and Ezrin\/Radixin\/Moesin-binding Phosphoprotein 50 is regulated by PKA","volume":"100","author":"Naren","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA."},{"issue":"4","key":"10.1016\/j.pupt.2025.102385_bib26","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1039\/b924455g","article-title":"CFTR chloride channel in the apical compartments: spatiotemporal coupling to its interacting partners","volume":"2","author":"Li","year":"2010","journal-title":"Integr. Biol."},{"issue":"19","key":"10.1016\/j.pupt.2025.102385_bib38","doi-asserted-by":"crossref","first-page":"17320","DOI":"10.1074\/jbc.M212227200","article-title":"Stimulation of beta 2-adrenergic receptor increases cystic fibrosis transmembrane conductance regulator expression in human airway epithelial cells through a cAMP\/protein kinase A-independent pathway","volume":"278","author":"Taouil","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.pupt.2025.102385_bib27","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.93029","article-title":"Chronic \u03b22AR stimulation limits CFTR activation in human airway epithelia","volume":"3","author":"Brewington","year":"2018","journal-title":"JCI Insight"},{"issue":"10","key":"10.1016\/j.pupt.2025.102385_bib28","doi-asserted-by":"crossref","first-page":"6107","DOI":"10.1074\/jbc.274.10.6107","article-title":"beta3-adrenoceptor control the cystic fibrosis transmembrane conductance regulator through a cAMP\/protein kinase A-independent pathway","volume":"274","author":"Leblais","year":"1999","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.pupt.2025.102385_bib29","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1124\/mol.104.002097","article-title":"Transfected beta3- but not beta2-adrenergic receptors regulate cystic fibrosis transmembrane conductance regulator activity via a new pathway involving the mitogen-activated protein kinases extracellular signal-regulated kinases","volume":"67","author":"Robay","year":"2005","journal-title":"Mol. Pharmacol."},{"issue":"1","key":"10.1016\/j.pupt.2025.102385_bib30","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1165\/rcmb.2009-0372OC","article-title":"\u03b21, \u03b22, and \u03b23 adrenoceptors and Na+\/H+ exchanger regulatory factor 1 expression in human bronchi and their modifications in cystic fibrosis","volume":"44","author":"Bossard","year":"2011","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"11","key":"10.1016\/j.pupt.2025.102385_bib31","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/j.jacc.2017.01.016","article-title":"GRK2 regulates \u03b12-adrenergic receptor-dependent catecholamine release in human adrenal Chromaffin cells","volume":"69","author":"Cannavo","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"issue":"3","key":"10.1016\/j.pupt.2025.102385_bib32","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1124\/pr.113.008219","article-title":"Polymorphic variants of adrenoceptors: pharmacology, physiology, and role in disease","volume":"66","author":"Ahles","year":"2014","journal-title":"Pharmacol. Rev."},{"issue":"15","key":"10.1016\/j.pupt.2025.102385_bib33","doi-asserted-by":"crossref","first-page":"4280","DOI":"10.3390\/jcm11154280","article-title":"Sex\/gender- and age-related differences in \u03b2-adrenergic receptor signaling in cardiovascular diseases","volume":"11","author":"Liccardo","year":"2022","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.pupt.2025.102385_bib34","doi-asserted-by":"crossref","first-page":"E199","DOI":"10.1152\/ajpendo.2001.280.2.E199","article-title":"The putative beta4-adrenergic receptor is a novel state of the beta1-adrenergic receptor","volume":"280","author":"Granneman","year":"2001","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"46","key":"10.1016\/j.pupt.2025.102385_bib35","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2407728121","article-title":"Structural determinants of protein kinase A essential for CFTR channel activation","volume":"121","author":"Mih\u00e1lyi","year":"2024","journal-title":"Proc. Natl. Acad. Sci. USA."},{"issue":"Pt 3","key":"10.1016\/j.pupt.2025.102385_bib36","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1111\/j.1469-7793.2000.00637.x","article-title":"Deletion of phenylalanine 508 causes attenuated phosphorylation-dependent activation of CFTR chloride channels","volume":"3","author":"Wang","year":"2000","journal-title":"J. Physiol. 524 Pt"},{"issue":"5","key":"10.1016\/j.pupt.2025.102385_bib37","doi-asserted-by":"crossref","first-page":"L770","DOI":"10.1152\/ajplung.00262.2019","article-title":"G551D mutation impairs PKA-dependent activation of CFTR channel that can be restored by novel GOF mutations","volume":"319","author":"Wang","year":"2020","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"issue":"4","key":"10.1016\/j.pupt.2025.102385_bib39","first-page":"L827","article-title":"Regulation of ciliary beat frequency by both PKA and PKG in bovine airway epithelial cells","volume":"275","author":"Wyatt","year":"1998","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.pupt.2025.102385_bib40","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1146\/annurev.physiol.69.040705.141253","article-title":"Regulation of mammalian ciliary beating","volume":"69","author":"Salathe","year":"2007","journal-title":"Annu. Rev. Physiol."},{"issue":"3","key":"10.1016\/j.pupt.2025.102385_bib41","doi-asserted-by":"crossref","first-page":"L546","DOI":"10.1152\/ajplung.00107.2004","article-title":"Both cAMP and cGMP are required for maximal ciliary beat stimulation in a cell-free model of bovine ciliary axonemes","volume":"288","author":"Wyatt","year":"2005","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"issue":"4","key":"10.1016\/j.pupt.2025.102385_bib42","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.3390\/ijms22041920","article-title":"Targeting GRK5 for treating chronic Degenerative diseases","volume":"22","author":"Marzano","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.pupt.2025.102385_bib43","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1080\/14728222.2018.1406925","article-title":"GRK2 as a therapeutic target for heart failure","volume":"22","author":"Cannavo","year":"2018","journal-title":"Expert Opin. Ther. Targets"},{"issue":"2","key":"10.1016\/j.pupt.2025.102385_bib44","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1161\/HYPERTENSIONAHA.113.02043","article-title":"Negative impact of \u03b2-arrestin-1 on post-myocardial infarction heart failure via cardiac and adrenal-dependent neurohormonal mechanisms","volume":"63","author":"Bathgate-Siryk","year":"2014","journal-title":"Hypertension"},{"key":"10.1016\/j.pupt.2025.102385_bib45","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms10877","article-title":"Myocardial pathology induced by aldosterone is dependent on non-canonical activities of G protein-coupled receptor kinases","volume":"7","author":"Cannavo","year":"2016","journal-title":"Nat. Commun."},{"issue":"4922","key":"10.1016\/j.pupt.2025.102385_bib46","doi-asserted-by":"crossref","first-page":"1 1066","DOI":"10.1126\/science.2475911","article-title":"Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA","volume":"245","author":"Riordan","year":"1989","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.pupt.2025.102385_bib47","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.cellsig.2005.01.002","article-title":"Pathophysiological roles of G-pr doi: 10.1016\/j.cellsig.2004.12.011otein-coupled receptor kinases","volume":"17","author":"M\u00e9tay\u00e9","year":"2005","journal-title":"Cell. Signal."},{"issue":"3","key":"10.1016\/j.pupt.2025.102385_bib48","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0014-2999(01)01625-9","article-title":"Increased expression of G protein-coupled receptor kinases in cystic fibrosis lung","volume":"436","author":"Mak","year":"2002","journal-title":"Eur. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.pupt.2025.102385_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2025.111942","article-title":"Global functional genomics reveals GRK5 as a cystic fibrosis therapeutic target synergistic with current modulators","volume":"28","author":"Botelho","year":"2025","journal-title":"iScience"},{"issue":"19","key":"10.1016\/j.pupt.2025.102385_bib50","doi-asserted-by":"crossref","DOI":"10.3390\/ijms251910234","article-title":"Update on the role of \u03b22AR and TRPV1 in respiratory diseases","volume":"25","author":"Manti","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"5 Pt 3","key":"10.1016\/j.pupt.2025.102385_bib51","doi-asserted-by":"crossref","first-page":"S146","DOI":"10.1164\/ajrccm.158.supplement_2.13tac110","article-title":"The beta-adrenoceptor","volume":"158","author":"Johnson","year":"1998","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"8","key":"10.1016\/j.pupt.2025.102385_bib87","doi-asserted-by":"crossref","first-page":"9008","DOI":"10.1096\/fj.201900323R","article-title":"Specificity of NHERF1 regulation of GPCR signaling and function in human airway smooth muscle","volume":"33","author":"Pera","year":"2019","journal-title":"FASEB J."},{"issue":"Issue 14","key":"10.1016\/j.pupt.2025.102385_bib88","first-page":"2509","article-title":"Ligand-induced Dynamic changes in extended PDZ domains from NHERF1","volume":"425","author":"Bhattacharya","year":"2005","journal-title":"J. Mol. Biol."},{"issue":"2","key":"10.1016\/j.pupt.2025.102385_bib89","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.pharmthera.2005.04.004","article-title":"Macromolecular complexes of cystic fibrosis transmembrane conductance regulator and its interacting partners","volume":"108","author":"Li","year":"2005","journal-title":"Pharmacol. Ther."},{"issue":"6","key":"10.1016\/j.pupt.2025.102385_bib90","article-title":"The cystic fibrosis transmembrane conductance regulator (CFTR) uses its C-terminus to regulate the A2B adenosine receptor","volume":"9","author":"Watson","year":"2016","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.pupt.2025.102385_bib91","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1183\/13993003.01661-2015","article-title":"\u03b22-Adrenergic receptor agonists activate CFTR in intestinal organoids and subjects with cystic fibrosis","volume":"48","author":"Vijftigschild","year":"2016","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.pupt.2025.102385_bib52","doi-asserted-by":"crossref","first-page":"C819","DOI":"10.1152\/ajpcell.1998.274.3.C819","article-title":"Type II protein kinase A regulates CFTR in airway, pancreatic, and intestinal cells","volume":"274","author":"Steagall","year":"1998","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.pupt.2025.102385_bib53","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/S0016-5085(99)70502-0","article-title":"Stimulation of cystic fibrosis transmembrane conductance regulator-dependent short-circuit currents across DeltaF508 murine intestines","volume":"116","author":"Steagall","year":"1999","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.pupt.2025.102385_bib54","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1097\/00063198-200311000-00010","article-title":"Long-acting bronchodilators in cystic fibrosis","volume":"9","author":"Colombo","year":"2003","journal-title":"Curr. Opin. Pulm. Med."},{"issue":"2","key":"10.1016\/j.pupt.2025.102385_bib55","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1152\/jappl.1988.65.2.971","article-title":"Stimulation of ciliary beat frequency by autonomic agonists: in vivo","volume":"65","author":"Wong","year":"1988","journal-title":"J. Appl. Physiol."},{"issue":"6 Suppl","key":"10.1016\/j.pupt.2025.102385_bib56","doi-asserted-by":"crossref","first-page":"S291","DOI":"10.1067\/mai.2002.129704","article-title":"Effect of beta-adrenergic agonists on mucociliary clearance","volume":"110","author":"Bennett","year":"2002","journal-title":"J. Allergy Clin. Immunol."},{"issue":"2","key":"10.1016\/j.pupt.2025.102385_bib57","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/j.1476-5381.1994.tb13100.x","article-title":"Effect of Salmeterol on human nasal epithelial cell ciliary beating: inhibition of the ciliotoxin, pyocyanin","volume":"112","author":"Kanthakumar","year":"1994","journal-title":"Br. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.pupt.2025.102385_bib58","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202100717RR","article-title":"Beta adrenergic receptor antagonist can modify Pseudomonas aeruginosa biofilm formation in vitro: implications for chronic wounds","volume":"36","author":"Medina Lopez","year":"2022","journal-title":"FASEB J."},{"issue":"3","key":"10.1016\/j.pupt.2025.102385_bib59","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0014-2999(95)00416-I","article-title":"The effects of formoterol, a long-acting beta 2-adrenoceptor agonist, on mucociliary activity","volume":"285","author":"Lindberg","year":"1995","journal-title":"Eur. J. Pharmacol."},{"issue":"10","key":"10.1016\/j.pupt.2025.102385_bib60","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1161\/hh2201.100204","article-title":"beta(2)-adrenergic receptor overexpression increases alveolar fluid clearance and responsiveness to endogenous catecholamines in rats","volume":"89","author":"Dumasius","year":"2001","journal-title":"Circ. Res."},{"issue":"4","key":"10.1016\/j.pupt.2025.102385_bib61","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1165\/rcmb.2008-0037OC","article-title":"Salmeterol restores secretory functions in cystic fibrosis airway submucosal gland serous cells","volume":"40","author":"Delavoie","year":"2009","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"4","key":"10.1016\/j.pupt.2025.102385_bib92","doi-asserted-by":"crossref","first-page":"357","DOI":"10.3390\/cells8040357","article-title":"Everything you always wanted to know about \u03b23-AR \u2217 (\u2217 but were afraid to ask)","volume":"8","author":"Schena","year":"2019","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.pupt.2025.102385_bib62","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1378\/chest.103.3.805","article-title":"Reduced effect of inhaled beta 2-adrenergic agonists on lung mucociliary clearance in patients with cystic fibrosis","volume":"103","year":"1993","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.pupt.2025.102385_bib63","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1165\/ajrcmb\/8.3.334","article-title":"Mutations in the gene encoding for the beta 2-adrenergic receptor in normal and asthmatic subjects","volume":"8","author":"Reihsaus","year":"1993","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"32","key":"10.1016\/j.pupt.2025.102385_bib64","doi-asserted-by":"crossref","first-page":"9414","DOI":"10.1021\/bi00198a006","article-title":"Amino-terminal polymorphisms of the human beta 2-adrenergic receptor impart distinct agonist-promoted regulatory properties","volume":"33","author":"Green","year":"1994","journal-title":"Biochemistry"},{"issue":"5","key":"10.1016\/j.pupt.2025.102385_bib65","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/00008571-200207000-00002","article-title":"beta2 adrenoceptor gene polymorphisms in cystic fibrosis lung disease","volume":"12","author":"B\u00fcscher","year":"2002","journal-title":"Pharmacogenetics"},{"issue":"8","key":"10.1016\/j.pupt.2025.102385_bib66","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1161\/01.CIR.103.8.1048","article-title":"Blunted cardiac responses to receptor activation in subjects with Thr164Ile beta(2)-adrenoceptors","volume":"103","author":"Brodde","year":"2001","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.pupt.2025.102385_bib67","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1002\/ppul.20210","article-title":"Beta 2 adrenergic receptor polymorphisms in cystic fibrosis","volume":"39","author":"Hart","year":"2005","journal-title":"Pediatr. Pulmonol."},{"key":"10.1016\/j.pupt.2025.102385_bib68","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1471-2466-12-50","article-title":"Polymorphisms in ADRB2 gene can modulate the response to bronchodilators and the severity of cystic fibrosis","volume":"12","author":"Marson","year":"2012","journal-title":"BMC Pulm. Med."},{"issue":"1","key":"10.1016\/j.pupt.2025.102385_bib69","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.arcmed.2018.04.010","article-title":"Influence of SNPs in genes that modulate lung disease severity in a group of Mexican patients with cystic fibrosis","volume":"49","author":"Yokoyama","year":"2018","journal-title":"Arch. Med. Res."},{"key":"10.1016\/j.pupt.2025.102385_bib70","doi-asserted-by":"crossref","DOI":"10.1016\/j.exger.2024.112420","article-title":"Age and sex mediated effects of estrogen and \u03923-adrenergic receptor on cardiovascular pathophysiology","volume":"190","author":"Corbi","year":"2024","journal-title":"Exp. Gerontol."},{"issue":"7","key":"10.1016\/j.pupt.2025.102385_bib71","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1161\/CIRCRESAHA.122.321583","article-title":"\u03b23AR-Dependent Brain-Derived Neurotrophic factor (BDNF) generation limits chronic Postischemic heart failure","volume":"132","author":"Cannavo","year":"2023","journal-title":"Circ. Res."},{"issue":"1","key":"10.1016\/j.pupt.2025.102385_bib72","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/s00395-022-00966-z","article-title":"Beta-3 adrenergic receptor overexpression reverses aortic stenosis-induced heart failure and restores balanced mitochondrial dynamics","volume":"117","author":"Pun-Garc\u00eda","year":"2022","journal-title":"Basic Res. Cardiol."},{"issue":"2","key":"10.1016\/j.pupt.2025.102385_bib73","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jacc.2017.05.020","article-title":"\u03b21-Blockade Prevents post-ischemic myocardial decompensation via \u03b23AR-dependent protective Sphingosine-1 phosphate signaling","volume":"70","author":"Cannavo","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.pupt.2025.102385_bib74","article-title":"Drugs currently undergoing preclinical or clinical trials for the treatment of overactive bladder: a review","volume":"96","author":"Joseph","year":"2022","journal-title":"Curr. Ther. Res. Clin.1 Exp."},{"issue":"3","key":"10.1016\/j.pupt.2025.102385_bib75","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/ejhf.2745","article-title":"\u03b23 adrenergic agonist treatment in chronic pulmonary hypertension associated with heart failure (SPHERE-HF): a double blind, placebo-controlled, randomized clinical trial","volume":"25","author":"Garc\u00eda-\u00c1lvarez","year":"2023","journal-title":"Eur. J. Heart Fail."},{"issue":"1","key":"10.1016\/j.pupt.2025.102385_bib93","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/j.1476-5381.2009.00328.x","article-title":"Cross-regulation between beta 1- and beta 3-adrenoceptors following chronic beta-adrenergic stimulation in neonatal rat cardiomyocytes","volume":"158","author":"Ufer","year":"2009","journal-title":"Br. J. Pharmacol."},{"issue":"5","key":"10.1016\/j.pupt.2025.102385_bib80","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1111\/j.1476-5381.2010.00754.x","article-title":"The selectivity of beta-adrenoceptor agonists at human beta1-, beta2- and beta3-adrenoceptors","volume":"160","author":"Baker","year":"2010","journal-title":"Br. J. Pharmacol."},{"issue":"44","key":"10.1016\/j.pupt.2025.102385_bib94","doi-asserted-by":"crossref","first-page":"18825","DOI":"10.1073\/pnas.0904709106","article-title":"Rescue of CF airway epithelial cell function in vitro by a CFTR potentiator, VX-770","volume":"106","author":"Van Goor","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.pupt.2025.102385_bib76","doi-asserted-by":"crossref","first-page":"222","DOI":"10.3390\/diagnostics10040222","article-title":"Salivary cytokines and airways disease severity in patients with cystic fibrosis","volume":"10","author":"Castaldo","year":"2020","journal-title":"Diagnostics"},{"key":"10.1016\/j.pupt.2025.102385_bib77","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.molimm.2023.06.011","article-title":"Pro-inflammatory action of formoterol in human bronchial epithelia","volume":"160","author":"Liu","year":"2023","journal-title":"Mol. Immunol."},{"issue":"6","key":"10.1016\/j.pupt.2025.102385_bib78","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.rmed.2006.11.014","article-title":"Effect of formoterol and salmeterol on IL-6 and IL-8 release in airway epithelial cells","volume":"101","author":"Strandberg","year":"2007","journal-title":"Respir. Med."},{"issue":"3","key":"10.1016\/j.pupt.2025.102385_bib79","doi-asserted-by":"crossref","first-page":"239","DOI":"10.2332\/allergolint.11-RAI-0317","article-title":"Pharmacogenetics of \u03b22-agonists","volume":"60","author":"Hizawa","year":"2011","journal-title":"Allergol. Int."},{"issue":"11","key":"10.1016\/j.pupt.2025.102385_bib81","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3389\/fphar.2020.00113","article-title":"The regulator of G protein signaling homologous domain of G protein-coupled receptor kinase 2 mediates short-term desensitization of \u03b23-adrenergic receptor","volume":"21","author":"Echeverr\u00eda","year":"2020","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.pupt.2025.102385_bib82","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1172\/JCI8374","article-title":"Albuterol-induced downregulation of Gsalpha accounts for pulmonary beta(2)-adrenoceptor desensitization in vivo","volume":"106","author":"Finney","year":"2000","journal-title":"J. Clin. Investig."},{"issue":"2","key":"10.1016\/j.pupt.2025.102385_bib83","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1124\/jpet.115.228411","article-title":"\u03b2 adrenergic receptor kinase C-terminal peptide gene-therapy improves \u03b22-adrenergic receptor-dependent Neoangiogenesis after Hindlimb Ischemia","volume":"356","author":"Cannavo","year":"2016","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"18","key":"10.1016\/j.pupt.2025.102385_bib95","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1056\/NEJMoa1105185","article-title":"A CFTR potentiator in patients with cystic fibrosis and the G551D mutation","volume":"365","author":"Ramsey","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"21","key":"10.1016\/j.pupt.2025.102385_bib96","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1056\/NEJMoa0909825","article-title":"Effect of VX-770 in persons with cystic fibrosis and the G551D-CFTR mutation","volume":"363","author":"Accurso","year":"2010","journal-title":"N. Engl. J. Med."},{"issue":"18","key":"10.1016\/j.pupt.2025.102385_bib97","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1056\/NEJMc1510466","article-title":"Lumacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR","volume":"373","author":"Wainwright","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.pupt.2025.102385_bib84","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1183\/23120541.00127-2017","article-title":"The potentially beneficial central nervous system activity profile of ivacaftor and its metabolites","volume":"4","author":"Schneider","year":"2018","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.pupt.2025.102385_bib85","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/164_2023_679","article-title":"Asthma and COPD: a focus on beta-agonists - past, present and future","volume":"285","author":"Baker","year":"2024","journal-title":"Handb. Exp. Pharmacol."},{"issue":"1","key":"10.1016\/j.pupt.2025.102385_bib86","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/pr.118.016899","article-title":"G protein-coupled receptors in asthma therapy: pharmacology and drug action","volume":"72","author":"Wendell","year":"2020","journal-title":"Pharmacol. Rev."}],"container-title":["Pulmonary Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094553925000422?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094553925000422?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T12:03:14Z","timestamp":1756900994000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1094553925000422"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":97,"alternative-id":["S1094553925000422"],"URL":"https:\/\/doi.org\/10.1016\/j.pupt.2025.102385","relation":{},"ISSN":["1094-5539"],"issn-type":[{"type":"print","value":"1094-5539"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploring the role of \u03b22- and \u03b23-adrenergic receptors in cystic fibrosis","name":"articletitle","label":"Article Title"},{"value":"Pulmonary Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pupt.2025.102385","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102385"}}